Literature DB >> 15148262

Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Marnie Duncan1, Paul Millns, Darren Smart, James E Wright, David A Kendall, Vera Ralevic.   

Abstract

1 Noladin ether has recently been reported to be an endocannabinoid, with selectivity for the cannabinoid (CB) CB1 receptor. In the present study, we investigated the effects of noladin ether in the rat isolated mesenteric arterial bed, cultured dorsal root ganglia (DRG) cells and human vanilloid (TRPV1)-receptor-expressing HEK293 cells (TRPV1-HEK293 cells). 2 Electrical field stimulation of the mesenteric bed evoked frequency-dependent vasorelaxation due to the action of calcitonin gene-related peptide (CGRP) released from sensory nerves. Noladin ether (0.1-3 microm) attenuated sensory neurogenic relaxation in a concentration-dependent manner. Noladin ether (1 microm) reduced vasorelaxation at a submaximal frequency (8 Hz), from 57.3+/-6.8 to 23.3+/-3.8% (P<0.05, n=4). 3 The inhibitory effects of noladin ether were unaffected by the CB1 antagonists SR141716A and LY320135, and the CB2 antagonist SR144528 (1 microm). 4 Noladin ether had no effect on vasorelaxation elicited by exogenous CGRP or capsaicin. These data suggest that noladin ether is acting at a prejunctional site and no interaction with TRPV1 is involved. 5 In mesenteric beds from pertussis toxin (PTX)-pretreated rats, the inhibitory actions of noladin ether on sensory neurotransmission were abolished, indicating the involvement of G(i/o) protein-coupled receptors. 6 Noladin ether evoked a concentration-dependent increase in intracellular Ca2+ concentration in TRPV1-HEK293 cells at 10 microm (36.5+/-3.2% of maximal capsaicin-induced response), but it was a less potent agonist than both capsaicin and anandamide and at 1 microm it was essentially inactive. Noladin ether (1 microm) had no effect on capsaicin-evoked Ca2+ responses in DRG cells, and produced no response alone, indicating it neither modulates nor acts directly on TRPV1 receptors. 7 These data demonstrate that noladin ether attenuates sensory neurotransmission in rat mesenteric arteries via a non-CB1 non-CB2 PTX-sensitive prejunctional site, independently of TRPV1 receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148262      PMCID: PMC1574960          DOI: 10.1038/sj.bjp.0705789

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology.

Authors:  D Smart; J C Jerman; M J Gunthorpe; S J Brough; J Ranson; W Cairns; P D Hayes; A D Randall; J B Davis
Journal:  Eur J Pharmacol       Date:  2001-04-06       Impact factor: 4.432

2.  Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

Authors:  C S Breivogel; G Griffin; V Di Marzo; B R Martin
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

3.  The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype.

Authors:  A Rubino; V Ralevic; G Burnstock
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

4.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

5.  Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line.

Authors:  R A Bundey; D A Kendall
Journal:  Neuropharmacology       Date:  1999-01       Impact factor: 5.250

Review 6.  Pharmacology of cannabinoid receptor ligands.

Authors:  R G Pertwee
Journal:  Curr Med Chem       Date:  1999-08       Impact factor: 4.530

7.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

8.  Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons.

Authors:  R M Lindsay
Journal:  J Neurosci       Date:  1988-07       Impact factor: 6.167

9.  Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Authors:  Marnie Duncan; Paul Millns; Darren Smart; James E Wright; David A Kendall; Vera Ralevic
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 10.  Anandamide receptors.

Authors:  Vincenzo Di Marzo; L De Petrocellis; F Fezza; A Ligresti; T Bisogno
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

View more
  13 in total

Review 1.  The complications of promiscuity: endocannabinoid action and metabolism.

Authors:  S P H Alexander; D A Kendall
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 2.  Cannabinoid control of neurogenic inflammation.

Authors:  Meagan McKenna; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

4.  Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Michael P Endsley; Jeffrey E Woodliff; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-12-15       Impact factor: 3.072

5.  Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.

Authors:  Marnie Duncan; Paul Millns; Darren Smart; James E Wright; David A Kendall; Vera Ralevic
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 6.  Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-22       Impact factor: 4.147

7.  Monoacylglycerols activate capsaicin receptor, TRPV1.

Authors:  Yusaku Iwasaki; Orine Saito; Manabu Tanabe; Kimiko Inayoshi; Kenji Kobata; Shuichi Uno; Akihito Morita; Tatsuo Watanabe
Journal:  Lipids       Date:  2008-05-15       Impact factor: 1.880

8.  Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.

Authors:  Y Sun; S P H Alexander; M J Garle; C L Gibson; K Hewitt; S P Murphy; D A Kendall; A J Bennett
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

9.  Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome.

Authors:  Mélissa Shen; Claudia Manca; Francesco Suriano; Nayudu Nallabelli; Florent Pechereau; Bénédicte Allam-Ndoul; Fabio Arturo Iannotti; Nicolas Flamand; Alain Veilleux; Patrice D Cani; Cristoforo Silvestri; Vincenzo Di Marzo
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

Review 10.  Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Isabella Wimmer; Johannes Berger
Journal:  Neurobiol Dis       Date:  2020-08-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.